Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lamb Weston | LW | Nov 15, 2024 | 75.47 | -6.14 |
Lancaster Colony | LANC | Nov 15, 2024 | 180.75 | -1.86 |
Landbridge Company | LB | Nov 15, 2024 | 68.87 | +5.00 |
Landmark Bancorp | LARK | Nov 15, 2024 | 22.06 | 0.00 |
Lands End | LE | Nov 15, 2024 | 15.40 | -4.41 |
Landsea Homes | LSEA | Nov 15, 2024 | 10.49 | -2.78 |
Landstar System | LSTR | Nov 15, 2024 | 182.82 | -2.45 |
Lantern Pharma | LTRN | Nov 15, 2024 | 3.54 | +1.43 |
Lantheus | LNTH | Nov 15, 2024 | 76.83 | -4.96 |
Lantronix | LTRX | Nov 15, 2024 | 2.83 | +0.35 |
Lanvin Group | LANV | Nov 15, 2024 | 1.80 | +13.92 |
Lanzatech Global | LNZA | Nov 15, 2024 | 1.09 | -11.07 |
Largecap Core Alphadex First Trust | FEX | Nov 15, 2024 | 108.66 | -0.33 |
Largecap Dividend Wisdomtree | DLN | Nov 15, 2024 | 79.80 | -0.67 |
Largecap ETF Vanguard | VV | Nov 15, 2024 | 269.45 | -1.27 |
Largecap Growth Opp Alphadex First Trust | FTC | Nov 15, 2024 | 141.46 | -0.39 |
Largecap Value Opp Alphadex First Trust | FTA | Nov 15, 2024 | 80.85 | -0.11 |
Largo | LGO | Nov 15, 2024 | 1.95 | -3.94 |
Larimar Therapeutics | LRMR | Nov 15, 2024 | 6.69 | -11.62 |
Las Vegas Sands | LVS | Nov 15, 2024 | 47.96 | -1.17 |
Laser Photonics | LASE | Nov 15, 2024 | 5.05 | -1.94 |
Latham Group | SWIM | Nov 15, 2024 | 5.71 | -2.31 |
Latin America Alphadex First Trust | FLN | Nov 15, 2024 | 16.75 | -0.13 |
Lattice Semiconductor | LSCC | Nov 15, 2024 | 49.23 | -2.77 |
Launch One Acquisition | LPAAU | Nov 15, 2024 | 10.02 | -0.20 |
Launch One Acquisition | LPAA | Nov 15, 2024 | 10.00 | 0.00 |
Launch Two Acquisition Units | LPBBU | Nov 15, 2024 | 9.99 | 0.00 |
Laureate Education | LAUR | Nov 15, 2024 | 18.51 | +1.15 |
LAVA Therapeutics | LVTX | Nov 15, 2024 | 1.57 | -5.42 |
Lavoro | LVRO | Nov 15, 2024 | 4.67 | -1.27 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.